Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Neogen Corp (NEOG) director reported an RSU vesting on October 27, 2025: 3,553 shares of common stock were acquired via a code “M” conversion at $6.07 per share. Following the settlement, the reporting person beneficially owns 47,913 shares, held directly.
Each RSU equaled one share, and the RSUs vested and were settled for an equal number of shares on October 27, 2025.
Neogen Corporation filed an amended report to update information about a recent board appointment. The company previously disclosed that Avi Pelossof would join its Board of Directors effective October 24, 2025. This amendment adds details on his governance roles.
Neogen states that Mr. Pelossof has been appointed to serve on its Audit Committee and its Compensation and Talent Management Committee. The change clarifies his specific committee responsibilities, which were determined after the original report filed on August 14, 2025.
Neogen Corp (NEOG) reported a routine insider equity event. A director converted restricted stock units into common shares on 10/27/2025 (Transaction Code M). 2,025 shares of common stock were acquired at $6.19 per share upon RSU vesting and settlement. Following the transaction, the director beneficially owns 30,725 shares directly. The filing also lists 4,050 derivative securities (RSUs) beneficially owned after the reported transaction.
Neogen Corp (NEOG) reported an insider equity change by a director. On October 27, 2025, 2,025 restricted stock units vested and were settled into 2,025 shares of common stock (transaction code M) at a listed price of $6.19 per share. Following this settlement, the reporting person directly owned 94,570 shares.
Neogen Corporation (NEOG) reported an insider transaction by a director. On 10/24/2025, the director acquired 19,386 shares of common stock at a $6.19 price and now holds 19,386 shares directly.
The filing also reports a grant of 49,929 stock options with a $6.19 exercise price, expiring on 10/24/2035. The options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corp (NEOG) filed a Form 3 for a reporting person serving as a Director. The filing states that no securities are beneficially owned. The event date is 10/24/2025, and the form was filed by one reporting person. The document is signed by Attorney in Fact Christopher Sefcheck on 10/28/2025.
Neogen Corp (NEOG) Form 4: A company director reported transactions dated 10/23/2025. The filer acquired 19,769 shares of common stock at $6.07, bringing directly held shares to 35,084 after the transaction. The filing indicates direct ownership.
The director was also awarded options covering 50,814 shares at an exercise price of $6.07, expiring 10/23/2035. According to the footnote, options and RSUs vest in equal annual installments on each of the first three anniversaries of the grant.
Neogen Corp (NEOG) — Form 4 insider report: A company director reported acquiring 19,769 shares of common stock on 10/23/2025 at $6.07 per share, bringing direct beneficial ownership to 19,769 shares. The filer also received a grant of options for 50,814 shares at a $6.07 exercise price, expiring 10/23/2035. Per the footnote, these awards vest in equal annual installments on each of the first three anniversaries of the grant date.
Neogen (NEOG) filed a Form 4 reporting director equity awards. On 10/23/2025, the reporting person acquired 19,769 shares of common stock at $6.07. Following this, directly held common stock totaled 36,788 shares.
The filing also reports 50,814 stock options granted at an exercise price of $6.07, expiring on 10/23/2035, with 50,814 derivative securities beneficially owned after the transaction. Per the footnote, options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.
Neogen Corporation (NEOG) director reported equity grants. On 10/23/2025, the insider acquired 19,769 shares of common stock at $6.07 per share, bringing direct beneficial ownership to 43,757 shares. The filer also reported a grant of options to buy 50,814 shares at an exercise price of $6.07, expiring on 10/23/2035. According to the footnote, the options and RSUs vest in equal annual installments on each of the first three anniversaries of the grant date.